The role of hyperthermia in regional alkylating agent chemotherapy
- PMID: 15355925
- DOI: 10.1158/1078-0432.CCR-04-0096
The role of hyperthermia in regional alkylating agent chemotherapy
Abstract
The role of hyperthermia during regional alkylating agent chemotherapy is controversial. The aim of this study was to determine the exact contribution of hyperthermia to tumor response during isolated limb infusion with l-phenylalanine mustard. Rats bearing rodent fibrosarcoma on the hindlimb underwent isolated limb infusion with saline, saline plus heat, l-phenylalanine mustard, l-phenylalanine mustard under conditions of normothermia, or l-phenylalanine mustard plus hyperthermia. Heat was administered locally using an in-line hot water circulation loop. Treatment with l-phenylalanine mustard at a concentration of 15 or 50 micrograms/mL was ineffective at producing tumor growth delay (P = 0.24 and 0.41, respectively). Furthermore, thermal enhancement of l-phenylalanine mustard activity was not seen at 15 micrograms/mL. However, administration of high-dose l-phenylalanine mustard, 50 micrograms/mL, with increasing amounts of heat yielded increasing tumor growth delay, increased regressions, and decreased proliferative index. Although l-phenylalanine mustard infusion under normothermia yielded a tumor growth delay of 7.1 days, combination l-phenylalanine mustard + hyperthermia treatment produced tumor growth delay of 27.0 days (P < 0.01; with two of five animals showing a complete response). Four hours after isolated limb infusion, 50.9% of cells in tumor treated with l-phenylalanine mustard + hyperthermia experienced apoptosis, whereas only 18.1, 16, and 4.4% of cells underwent apoptosis after treatment with l-phenylalanine mustard, saline + hyperthermia, or saline. The mean concentration of l-phenylalanine mustard within tumor relative to perfusate following isolated limb infusion was found to be similar among all groups at 0.023, 0.025, and 0.032 in animals undergoing isolated limb infusion with l-phenylalanine mustard, l-phenylalanine mustard + normothermia, and l-phenylalanine mustard + hyperthermia, respectively. These data indicate a synergistic cytotoxic effect of l-phenylalanine mustard + hyperthermia in isolated limb infusion, which is not attributable to enhanced tumor drug uptake.
Similar articles
-
Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.Cancer Chemother Pharmacol. 2006 Dec;58(6):719-24. doi: 10.1007/s00280-006-0229-2. Epub 2006 Apr 14. Cancer Chemother Pharmacol. 2006. PMID: 16614851
-
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity.Clin Cancer Res. 2006 Jan 1;12(1):289-97. doi: 10.1158/1078-0432.CCR-05-0210. Clin Cancer Res. 2006. PMID: 16397054
-
Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia.Int J Hyperthermia. 2008 Nov;24(7):602-3; author reply 604. doi: 10.1080/02656730802235536. Int J Hyperthermia. 2008. PMID: 18979311 No abstract available.
-
Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.Anticancer Res. 1997 Jul-Aug;17(4B):2891-4. Anticancer Res. 1997. PMID: 9329556 Review.
-
Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.Int J Hyperthermia. 2008 May;24(3):193-203. doi: 10.1080/02656730701868387. Int J Hyperthermia. 2008. PMID: 18392998 Review.
Cited by
-
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?Ann Surg Oncol. 2009 Apr;16(4):953-61. doi: 10.1245/s10434-008-0288-1. Epub 2009 Jan 30. Ann Surg Oncol. 2009. PMID: 19184236 Free PMC article.
-
Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1383-94. doi: 10.1517/17425255.2011.609555. Epub 2011 Oct 7. Expert Opin Drug Metab Toxicol. 2011. PMID: 21978383 Free PMC article. Review.
-
Regional treatment strategies for in-transit melanoma metastasis.Surg Oncol Clin N Am. 2011 Jan;20(1):79-103. doi: 10.1016/j.soc.2010.09.008. Surg Oncol Clin N Am. 2011. PMID: 21111960 Free PMC article. Review.
-
Systemic anti-tumour effects of local thermally sensitive liposome therapy.Int J Hyperthermia. 2014 Sep;30(6):385-92. doi: 10.3109/02656736.2014.944587. Epub 2014 Aug 28. Int J Hyperthermia. 2014. PMID: 25164143 Free PMC article.
-
Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).Surg Today. 2015 Mar;45(3):355-62. doi: 10.1007/s00595-014-0952-y. Epub 2014 Jul 8. Surg Today. 2015. PMID: 24998594
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources